Core Viewpoint - Huahai Qingke (688120.SH), a leading domestic semiconductor CMP equipment supplier, plans to issue H-shares and list on the Hong Kong Stock Exchange to accelerate its international strategy and overseas business layout [1][4]. Group 1: Financial Performance - In the first half of 2025, Huahai Qingke achieved operating revenue of 1.95 billion yuan, a year-on-year increase of 30.28%, and a net profit attributable to shareholders of 505 million yuan, up 16.82% [2][3]. - For the year 2024, the company reported operating revenue of 3.406 billion yuan, a growth of 35.82%, and a net profit of 1.023 billion yuan, increasing by 41.40% [2][3]. - The company's cash flow from operating activities in the first half of 2025 increased by 6.17% to 395 million yuan [3]. Group 2: Business Strategy and Development - Huahai Qingke focuses on R&D and production capacity enhancement to strengthen its core competitiveness, particularly in CMP products, which are essential for integrated circuit manufacturing [3][4]. - The company has a comprehensive platform strategy that includes equipment and services, with products widely used in integrated circuits, advanced packaging, and other manufacturing processes [2][3]. - The company is expanding its production base and optimizing its industrial layout, with a new factory in Beijing and a project in Kunshan to increase wafer regeneration capacity [7]. Group 3: Intellectual Property and R&D Investment - As of June 30, 2025, Huahai Qingke has obtained 500 authorized patents and 39 software copyrights, emphasizing its commitment to technological innovation [6]. - The company's R&D investment in the first half of 2025 was 246 million yuan, a year-on-year increase of 40.44%, accounting for 12.63% of its operating revenue [6]. Group 4: Market Position and Future Outlook - If successful in its Hong Kong listing, Huahai Qingke will be the first company under Sichuan Energy Development Group to be listed on both A-share and Hong Kong markets, enhancing its international brand image and capital structure [4]. - The company has a strong order backlog, with contract liabilities reaching 1.755 billion yuan, a 30.81% increase, supporting its ongoing performance [7].

Core Viewpoint - Huahai Qingshi (688120) plans to expand its wafer regeneration project to enhance its "equipment + service" platform development strategy, aiming to capture the growing market share in the semiconductor equipment industry [1][2]. Group 1: Expansion Plans - The company intends to build a wafer regeneration expansion project in Kunshan, Jiangsu Province, with a total planned capacity of 400,000 pieces per month, and an initial construction capacity of 200,000 pieces per month [1]. - The initial investment for the project is expected to be no more than 500 million yuan, funded by the company's own and self-raised funds, with a construction period of no more than 18 months [1]. Group 2: Technology and Market Position - The wafer regeneration process involves multiple steps, including film removal, coarse grinding, fine grinding, cleaning, and inspection, aimed at ensuring a smooth surface without residual particles [1]. - The company has established strong relationships with domestic integrated circuit manufacturers, which overlap significantly with its existing equipment business customer base, laying a solid foundation for market expansion in wafer regeneration [2]. Group 3: Financial Performance - In 2024, the company achieved total operating revenue of 3.406 billion yuan, a year-on-year increase of 35.81%, and a net profit attributable to shareholders of 1.023 billion yuan, up 41.4% [2]. - Revenue from wafer regeneration and other businesses totaled 419 million yuan, reflecting an approximate 80% year-on-year growth, outpacing the growth of the main CMP/thinning equipment sales [2]. Group 4: Strategic Development - The company is committed to the "equipment + service" platform development strategy, focusing on semiconductor key equipment and technical services, and actively developing new technologies and products [3]. - The revenue from CMP equipment continues to grow rapidly, while thinning equipment, wet processing equipment, and wafer regeneration services are also contributing significantly to overall revenue [3].

Core Viewpoint - The company is preparing for its 2024 Annual General Meeting (AGM) to discuss various proposals, including profit distribution, financial reports, and compensation plans for directors and supervisors, ensuring compliance with relevant laws and regulations [1][2][3]. Group 1: Meeting Procedures - The AGM will only allow attendance from shareholders, their proxies, company directors, supervisors, senior management, and invited legal representatives to maintain order and protect shareholder rights [1][2]. - Shareholders must sign in 30 minutes before the meeting and present necessary identification to receive meeting materials [2]. - The meeting will follow a predetermined agenda for reviewing and voting on proposals, with shareholders having the right to speak and ask questions [2][3]. Group 2: Proposals for Review - Proposal 1 involves the approval of the 2024 Annual Report and its summary, which has been prepared in accordance with legal requirements [5][6]. - Proposal 2 pertains to the 2024 Board of Directors' Work Report, emphasizing the board's diligence in promoting the company's stable development [7]. - Proposal 3 focuses on the 2024 Supervisory Board's Work Report, highlighting the board's commitment to safeguarding shareholder interests [8][9]. - Proposal 4 addresses the 2024 Financial Settlement Report, which has been audited and is intended to provide shareholders with a comprehensive understanding of the company's financial status [10]. Group 3: Profit Distribution and Capital Increase - Proposal 5 outlines the profit distribution plan for 2024, proposing a cash dividend of 5.50 yuan per 10 shares and a capital increase of 4.90 shares for every 10 shares held, based on a net profit of approximately 1.02 billion yuan [11][12]. - The total share capital will increase to approximately 352.47 million shares after the proposed distribution [11]. Group 4: Related Party Transactions - Proposal 6 discusses the confirmation of 2024 related party transactions and the expected transactions for 2025, which are necessary for the company's operations [13][14]. - The proposal includes details on the expected amounts and categories of transactions with related parties, ensuring compliance with market pricing principles [15][16]. Group 5: Compensation Plans - Proposal 7 addresses the confirmation of director compensation for 2024 and the proposed compensation plan for 2025, with non-independent directors receiving salaries based on their actual roles [24]. - Proposal 8 focuses on the compensation for supervisors, similar to the directors' compensation structure [25]. Group 6: Risk Management - Proposal 9 involves purchasing Directors, Supervisors, and Senior Management Liability Insurance to enhance the company's risk management framework [26][27].

Investment Rating - The investment rating for the company is "Accumulate" [1] Core Views - The company has demonstrated continuous rapid growth in performance, with a clear platform-based growth logic [2] - Revenue for 2024 reached 3.406 billion, a year-on-year increase of 35.82%, aligning with market expectations; Q1 2025 revenue was 912 million, up 34.14% year-on-year, driven by sufficient orders for CMP equipment and successful market expansion for new products [3] - The gross profit margin remains high, with a net profit of 1.023 billion for 2024, a year-on-year increase of 41.40%, outperforming revenue growth [4] - The company benefits from the expansion of advanced processes, with a clear platform-based logic in product offerings such as CMP and thinning equipment [6] Summary by Sections Revenue and Growth - In 2024, the company achieved revenue of 3.406 billion, a 35.82% increase year-on-year; Q1 2025 revenue was 912 million, a 34.14% increase year-on-year, primarily due to strong orders for CMP equipment and successful market expansion for new products [3] - The company’s inventory and contract liabilities as of Q1 2025 were 3.488 billion and 1.641 billion, respectively, reflecting increases of 27.67% and 33.86% year-on-year, indicating a continuous rise in orders [3] Profitability - The company reported a net profit of 1.023 billion for 2024, a 41.40% increase year-on-year, with a net profit margin of 30.05%, up 1.19 percentage points year-on-year [4] - The gross profit margin for 2024 was 43.20%, showing stability despite a slight decrease of 0.35 percentage points [4] - For Q1 2025, the net profit was 233 million, a 15.47% increase year-on-year, with a gross profit margin of 46.37%, up 1.18 percentage points year-on-year [5] Product Development and Market Position - The company is enhancing its product line, focusing on CMP and thinning equipment, which are expected to drive future growth [6] - The new CMP polishing system Universal-H300 has received repeat orders, and the thinning equipment has successfully passed multiple acceptance tests [6][7] - The company has established a comprehensive cleaning equipment layout covering various manufacturing fields, indicating a strong market position [7] Financial Forecast - Revenue forecasts for 2025 and 2026 have been adjusted to 4.554 billion and 5.866 billion, respectively, with year-on-year growth rates of 34% and 29% [8] - The net profit forecasts for 2025 and 2026 are 1.348 billion and 1.730 billion, with year-on-year growth rates of 32% and 28% [8] - The estimated EPS for 2025 and 2026 are 5.69 and 7.31, respectively [8]

Investment Rating - The investment rating for the company is "Buy-A" with a target price of 208.76 CNY per share, maintaining the rating [6][9]. Core Views - The company has demonstrated significant revenue and profit growth, with a 35.82% year-on-year increase in revenue to 3.406 billion CNY and a 41.4% increase in net profit to 1.023 billion CNY for the year 2024 [1][2]. - The company's CMP (Chemical Mechanical Planarization) equipment continues to lead the domestic market, with a 31.16% increase in sales revenue to 2.987 billion CNY in 2024 [3][4]. - The company is expanding its product lines and platform development, including advancements in cutting, polishing, and ion implantation equipment, which are currently undergoing client validation [4]. Summary by Sections Financial Performance - In 2024, the company achieved a revenue of 3.406 billion CNY, a year-on-year increase of 35.82%, and a net profit of 1.023 billion CNY, up 41.4% [1][2]. - For Q1 2025, the company reported a revenue of 912 million CNY, a 34.14% increase year-on-year, and a net profit of 233 million CNY, up 15.47% [1]. Profitability Metrics - The company's gross margin for 2024 was 43.2%, a decrease of 2.81 percentage points year-on-year, while the net margin improved to 30.05%, an increase of 1.19 percentage points [2]. Product Development - The company has successfully launched the Universal-H300 CMP system and developed specialized CMP equipment for third-generation semiconductors, which is currently in client validation [3]. - The company has made significant progress in domestic production of key components for its thinning equipment, meeting mass production requirements [3]. Market Position and Growth - The company maintains a leading market share in CMP equipment, with a strong focus on innovation and customer expansion, particularly in advanced process equipment [3][4]. - The company is expected to achieve revenues of 4.667 billion CNY, 5.833 billion CNY, and 6.883 billion CNY for the years 2025, 2026, and 2027, respectively [9].